Singapore markets close in 4 hours 13 minutes
Straits Times Index
3,337.86 +5.06 (+0.15%) Nikkei
39,613.52 +30.44 (+0.08%) Hang Seng
17,718.61 +2.11 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
63,201.54 +2,495.00 (+4.11%) CMC Crypto 200
1,312.72 +28.89 (+2.25%)
VRTX Jul 2024 475.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:26PM EDT. Market open.
| Previous close | 5.90 |
| Open | 3.80 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 475.00 |
| Expiry date | 2024-07-05 |
| Day's range | 3.80 - 5.90 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- GuruFocus.com
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
The transaction was executed at a price of $471.72 per share, as detailed in the SEC Filing. Following this sale, the insider now owns 30,099 shares of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biotechnology firm focused on developing and commercializing therapies for the treatment of cystic fibrosis and other severe diseases.
ZacksVertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
ZacksVertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
© 2024 Yahoo. All rights reserved.